Navigation Links
Clinical Research Management gets contract for trials of therapeutics against infectious diseases
Date:8/7/2008

Clinical Research Management, Inc. has a proven track record in supporting clinical trials, most notably in its fifteen years of work with the U.S. Army's Phase I/II clinical testing center at the Walter Reed Army Institute of Research in Silver Spring, MD. CRM is the premier clinical research organization supporting this center. When CRM decided to expand its infectious disease capabilities, it looked to the National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID)'s initiative to utilize Phase I Clinical Trial Units for Therapeutics Against Infectious Disease.

"Partnering with experienced testing sites for new products against infectious disease fits our corporate focus and strategic expansion goals. We saw this as a prime opportunity to collaborate with our nation's prestigious infectious disease organizations," said Victoria Tifft, President of Clinical Research Management.

"Our corporate headquarters is in Northeast Ohio and our region hosts some of the finest researchers in the nation and we are committed to bringing a portion of our work to this area," Tifft said.

To achieve the goals of the contract, Clinical Research Management selected Case Western Reserve University School of Medicine and University Hospitals Case Medical Center (UHCMC) and Johns Hopkins University to serve as national safety testing centers for therapeutic agents developed for use against infections. Dr Mac Griffiss, a leader in infectious disease research, will serve as CRM Global Principal Investigator for this multi-center effort.

"Our commitment to growing the bioscience community in Northeast Ohio led us to Dr. Robert Salata at Case Western Reserve University and University Hospitals Case Medical Center. Dr. Salata and his team have significant expertise in infectious disease and Phase I clinical trials that suited the requirements of this contract perfectly. We've worked with t
'/>"/>

Contact: George Stamatis
george.stamatis@UHhospitals.org
216-844-3667
University Hospitals of Cleveland
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. The Journal of Allergy and Clinical Immunology devotes special issue to AIDS
2. Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer
3. Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
4. Hospital Clínic participates in ICREL project about European legislation on clinical trials
5. Clinical Trial Concluded For New Wrinkle Treatment
6. Clinical Trial for the Treatment of Inflammatory Bowel Disease Begins at Tel Aviv Sourasky Medical Center
7. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
8. North Carolinas Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center
9. Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
10. Northwestern Memorial Among Americas Best Hospitals in 10 Clinical Specialties According to U.S. News 2008 Rankings
11. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... the Way, Brightening the Day, on Friday, May 1, ... Morristown, NJ. , Guests will enjoy an elegant ... delightful cuisine, an extensive silent auction and heart-warming testimony ... awards will be presented to this year’s honorees. ...
(Date:3/26/2015)... San Frencisco, CA (PRWEB) March 26, 2015 ... Implant Center are proud to announce expanded offerings for ... The San Francisco Dental Implant Center has long been ... efforts have expanded its offerings to meet the strong ... pride in our reputation as a top-rated dental implant ...
(Date:3/26/2015)... 2015 Innovative research and additional ... preventing often fatal ruptures, says The Bee Foundation, ... awareness of brain aneurysms and funding innovative research ... national attention with the death of longtime ... last Friday after suffering a ruptured brain aneurysm. ...
(Date:3/26/2015)... March 26, 2015 The National ... Assessment and Evaluation , has announced its partnership ... institutions, organizations, and corporations to accurately and securely ... learning. , Utilizing Questionmark’s state-of-the-art software and ... will offer improved delivery of the seventy-five to ...
(Date:3/26/2015)... Volunteers will collectively walk hundreds of miles ... funds to support the American Parkinson Disease Association’s ... the Cure. The Optimism Walk campaign is ... than 20 locations including, Boston, Chicago, Connecticut, Madison, Nashville, ... Seattle, St. Louis, New York, Nevada, South Florida, Vermont, ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2
... ... ... Wellness Center is now offering Kennedy Spinal Decompression Therapy to Springfield area residents suffering ... for lower back and neck pain sufferers., , ,Spinal Decompression Therapy has been clinically ...
... ... payroll processing time thus freeing staff to spend more time serving patients and less time ... ... improvement in staff productivity and payroll processing time thus freeing staff to spend more time ...
... ) today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to ... ... , , ... ...
... The Autism Consortium, an innovative research, clinical and family ... for families with autism spectrum disorders (ASDs), announced today ... testing methods for autism spectrum disorders is available from ... in their eFirst pages today and will appear in ...
... kind to date using cardiac computed tomography angiography, people ... artery disease are at higher risk of developing obstructive ... Ford Hospital researchers say. Researchers analyzed the data ... tomography angiography and found that those with a family ...
... ACL, meniscus at same time is one advance, ,Tommy John, ... Repairing a torn knee meniscus at the same time as ... children, a new study finds. , Meniscus cartilage acts as ... one of four major ligaments in the knee. , This ...
Cached Medicine News:Health News:Chiropractor Springfield, VA - Dr. Todd P. Sullivan Announces The Addition of Spinal Decompression Therapy 2Health News:Hospice of Baton Rouge Selects CellTrak as a Good Steward of Time and Talent 2Health News:Hospice of Baton Rouge Selects CellTrak as a Good Steward of Time and Talent 3Health News:Hospice of Baton Rouge Selects CellTrak as a Good Steward of Time and Talent 4Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 2Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 3Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 4Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 5Health News:Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests 2Health News:Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests 3Health News:Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests 4Health News:Family history is strong predictor of obstructive coronary artery disease using CCTA 2Health News:Strides Seen in Orthopedic Surgery for Kids 2
(Date:3/26/2015)... VEGAS , March 26, 2015 Zimmer ... Vivacit-E ® Advanced Bearing Technology with ... A paper published earlier this month reported that, ... Vivacit-E Advanced Bearing Technology featuring Vitamin E ... maintained a significant wear rate reduction of 95 percent, ...
(Date:3/26/2015)... 26 mars 2015 Finesse Solutions annonce ... pour les innovateurs, visionnaires et cadres de direction ... d,une durée de deux jours proposée exclusivement sur ... le centre ville de San Francisco ... Il s,agira d,un forum destiné aux leaders des ...
(Date:3/26/2015)... Utah , March 26, 2015  Flexpoint Sensor ... with new customers it has received and shipped during ... get a lot of interest in the sensors for ... these sensors or have had custom sensors built for ... LLC who received custom sensors for medical rehab; a ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Finesse Solutions annonce l'événement Cellworld 2015 2Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2
... and Non-Whites New to Antiretroviral Therapy Respond ... Similarly to ... treatment,regimens containing once-daily or twice-daily dosing of Abbott,s (NYSE:,ABT) protease ... (reducing the amount of HIV-1),and improving the immune system (increasing ...
... Tolerx, Inc., a,biopharmaceutical company engaged in the ... of immune-mediated diseases, announced today,that Genentech, a collaborator, ... anti-CD4 monoclonal antibody, into a phase 1 clinical ... is evaluating the,safety and tolerability of both single ...
Cached Medicine Technology:Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
... 1 (IGF-1) is a polypeptide of 70 amino ... number of related insulin-like growth factors present in ... homology with proinsulin and has a number of ... growth hormone (GH) dependent to a high degree, ...
...
...
...
Medicine Products: